(Alliance News) - The board of directors of Immsi Spa on Tuesday reviewed and approved the interim report for the nine months ended September 30, which closed with a profit of EUR22.7 million, virtually unchanged from last year. Net income before minorities was EUR58 million, up 8.2 percent from EUR53.6 million as of Sept. 30, 2022. The board then resolved to distribute an interim dividend of EUR0.15 on the ordinary dividend for fiscal year 2023.

Consolidated revenues as of September 30 amounted to EUR1.64 billion, roughly in line with revenues in the first nine months of last year.

Consolidated Ebitda for the Immsi group was EUR257.5 million - the highest value recorded in the period - up 12 percent from EUR230.5 million recorded as of Sept. 30, 2022. Ebitda margin was 15.6 percent, up from 13.9 percent as of September 30, 2022.

Consolidated Ebit was EUR146.4 million, up 16.1% from EUR126.1 million in the first nine months of 2022. Ebit margin stood at 8.9 percent, up from 7.6 percent as of Sept. 30, 2022.

Immsi Group's net debt as of Sept. 30, 2023 was EUR767.2 million from EUR731.7 as of Dec. 31, 2022.

Immsi on Tuesday trades in the green by 1.0 percent at EUR0.48 per share

By Maurizio Carta, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.